Capture probe for rubella virus full-length genome detection and kit and application thereof
By designing capture probes and second-generation sequencing technology for rubella virus, the problem of low sequencing coverage caused by high GC content and strain variability is solved, and efficient detection and mutation monitoring of the full-length genome of rubella virus is achieved, supporting viruses Traceability analysis.
Patent Information
- Application Number
- CN202411054540.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing probe hybrid capture combined with second-generation sequencing methods are difficult to cover genome sequences with high GC content and strain variability when detecting the full-length genome of rubella virus, resulting in low sequencing coverage and unable to meet the needs of virus tracing and traceability.
A capture probe for the full-length genome of rubella virus was designed. Combined with second-generation sequencing technology, high-throughput sequencing of the full-length genome of rubella virus was achieved through hybrid capture system, and 796 probes were used to cover the genome of all strains. and improve detection efficiency through labeling and magnetic bead separation techniques.
It has achieved efficient detection of the full-length genome of rubella virus, with a coverage of 100%, can monitor genomic mutations, supports virus type traceability, and provides fast and accurate virus monitoring and analysis tools.
Smart Images

Figure CN119040516A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of genome sequencing, and in particular relates to a capture probe for detecting the full-length genome of rubella virus, a kit and an application thereof. Background Art
[0002] Rubella is an acute respiratory infectious disease caused by rubella virus with fever and rash as its main characteristics. However, rubella virus is a teratogenic pathogen that can infect the fetus through the placenta, causing premature birth / stillbirth or congenital rubella syndrome after birth. According to the latest classification of the International Committee on Virological Nomenclature, rubella virus is a single-stranded positive-strand RNA virus belonging to the Rubivirus genus (Rubivirus) of the Matonaviridae family. It has only one serotype, but according to the target gene defined by the World Health Organization (WHO) (739 nucleotides of the E1 gene, E1-739), it can be divided into 13 genotypes (1a, 1B, 1C, 1D, 1E, 1F, 1G, 1H, 1I, 1J, 2A, 2B, 2C). With the widespread prevalence of 1E and 2B genotypes around the world, the typing method recommended by WHO can no longer meet the needs of virus tracking and tracing, so there is an urgent need for a method that can perform high-throughput sequencing and analysis of the entire genome of rubella virus.
[0003] At present, the detection method of probe hybridization capture combined with second-generation sequencing has been widely used in the detection fields of tumors, genetic diseases, etc. However, the detection of pathogen genomes is still in its preliminary stages. Probe hybridization capture has a huge application scenario in the field of pathogen detection due to its strong adaptability. For example, if a new virus is similar to a certain type of virus, its genome can be subjected to probe design and sequencing experiments. The detection method of probe hybridization capture combined with second-generation sequencing can understand unknown pathogens with extremely high efficiency and provide methods and means to prevent the spread of viruses with great probability.
[0004] However, this method also has its own limitations. For example, the strain has extremely low abundance in samples collected from the host, resulting in the inability of sequencing to cover the full-length genome sequence of the strain. Summary of the invention
[0005] In view of this, an object of the present invention is to provide a capture probe for full-length genome detection of Rubella virus, which can realize full-length genome detection of different Rubella virus strains.
[0006] The present invention provides a capture probe for detecting the full-length genome of rubella virus, and the nucleotide sequence is shown in SEQ ID NO: 1 to SEQ ID NO: 796.
[0007] Preferably, the capture probe is labeled with biotin.
[0008] The invention provides a kit for detecting the full-length genome of rubella virus, comprising the capture probe, magnetic beads labeled with streptavidin and a library hybridization reaction reagent.
[0009] Preferably, the library hybridization reaction reagents include at least one of the following reagents: TargetSeq HybBuffer v2, Hyb Human Block, Blocking Oligo and RNase Inhibitors.
[0010] Preferably, the kit further comprises RNA fragmentation reagents, reverse transcription reaction reagents, cDNA double-strand synthesis reaction reagents, linker connection reagents, purification reagents, PCR pre-reaction reagents and post-capture PCR amplification reaction reagents.
[0011] Preferably, the PCR pre-reaction reagents include at least one of the following: PCR Master Mix containing UDG enzyme and UDI primers;
[0012] The post-capture PCR amplification reaction reagents include at least one of the following: PCR primers and a post-capture PCR reaction premix.
[0013] The present invention provides the use of the capture probe or the kit in the detection of the full-length genome of rubella virus, the monitoring of rubella virus genome variation and / or the tracing analysis of the rubella virus genome.
[0014] Preferably, in the application, the kit is used to obtain the full-length genome of rubella virus, and obtain the variation information of the rubella virus genome, wherein the variation information includes single base mutation and insertion and deletion mutation; and the purpose of monitoring and / or tracing the source of the rubella virus genome variation is achieved by comparing and analyzing the variation information with the genome sequence in the database;
[0015] Preferably, the strain of Rubella virus includes the 1E rubella epidemic strain and / or the 2B rubella epidemic strain.
[0016] The present invention provides a method for detecting the full-length genome of rubella virus based on the capture probe and second-generation sequencing, comprising the following steps:
[0017] Hybridizing the Rubella virus genome library of the sample to be tested with the capture probe to obtain a hybridization reaction solution;
[0018] separating the DNA fragment hybridized with the probe from the hybridization reaction solution;
[0019] The DNA fragment hybridized with the probe is used as a template for post-capture PCR amplification, the obtained PCR product is subjected to second-generation sequencing, and the sequencing result is subjected to data analysis to obtain the full-length genome of the rubella virus.
[0020] Preferably, the method for performing data analysis on sequencing results includes preliminary filtering of raw sequencing data to obtain clean reads;
[0021] The host gene sequence is removed from the clean reads, and the obtained sequence is aligned to the viral genome to assemble a contig sequence;
[0022] The contig sequence is again depleted of the host gene sequence and then aligned to the viral genome sequence to obtain virus typing and sorting data;
[0023] The virus typing and sequencing data were aligned to the reference genome, and after correction of the variant sites, the full-length genome of the rubella virus was obtained.
[0024] The present invention provides a capture probe for full-length genome detection of rubella virus, and the nucleotide sequence is shown in SEQ ID NO: 1 to SEQ ID NO: 796. First, the capture probe provided by the present invention solves the detection difficulties caused by abnormal GC content. The rubella virus genome sequence is characterized by high GC content, with a GC content of about 70% for the whole genome and up to 80% for some regions. The method of using existing designed primers for amplification, first-generation sequencing, and then splicing the full-length genome is often impossible due to GC abnormality. Secondly, the capture probe can cover the full-length genome sequence of all strains. Due to the problem of variation in the viral genome, conventional first-generation sequencing cannot achieve the detection of the genome sequence of all strains of the virus using a set of primers. The method of combining probe hybridization capture with second-generation sequencing of the present invention can achieve coverage of all strains of rubella virus using a set of probe systems. Thirdly, the capture probe has a high throughput. Using the probe hybridization capture system combined with the second-generation sequencing technology, it is possible to achieve simultaneous sequencing of multiple samples, which has the advantages of high versatility, simplicity and speed compared with the conventional PCR method. Finally, the capture probe is used to capture the target region DNA to ensure high coverage of the genome sequence. By using a probe hybridization capture system combined with the second-generation sequencing technology, nearly 100% genome coverage can be achieved for any rubella virus genome sequence.
[0025] The present invention provides a kit for detecting the full-length genome of rubella virus, comprising the capture probe, streptavidin-labeled magnetic beads and library hybridization reaction reagents. The use of the kit can obtain the full genome information of rubella virus, and a set of kits can complete the full genome coverage of different types of rubella virus. On the basis of obtaining the full genome information of rubella virus, a large number of sample strain full genome databases can be established, which plays an important role in tracing the virus type in the rubella virus outbreak area. Based on the new mutation of any site on the rubella virus genome, the kit can effectively detect the mutation and accurately monitor the variation of rubella virus. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The sequencing results of position 6 of sample 1 by first-generation sequencing and second-generation sequencing based on the capture probe of the present invention;
[0027] Figure 2 The sequencing results of position 9697 of sample 1 by first-generation sequencing and second-generation sequencing based on the capture probe of the present invention;
[0028] Figure 3 The sequencing results of position 9758 of sample 1 by first-generation sequencing and second-generation sequencing based on the capture probe of the present invention;
[0029] Figure 4 The sequencing results of position 6 of sample 2 by first-generation sequencing and second-generation sequencing based on the capture probe of the present invention;
[0030] Figure 5 These are the sequencing results of position 9749 of sample 2 by first-generation sequencing and second-generation sequencing based on the capture probe of the present invention. DETAILED DESCRIPTION
[0031] The present invention provides a capture probe for detecting the full-length genome of rubella virus, the nucleotide sequence of which is shown in SEQ ID NO: 1 to SEQ ID NO: 796, and the specific sequence is shown in Table 1.
[0032] In the present invention, the capture probe is preferably labeled with biotin. The biotin labeling facilitates subsequent separation by hybridization of the capture probe with the target region DNA to form a complex.
[0033] In the present invention, there are 796 capture probes in total, which can fully cover the Rubella virus genome sequence, and have the characteristics of uniformity, specificity and high capture efficiency for the captured region. The capture probes are preferably synthesized by high-throughput electrochemical synthesis. In an embodiment of the present invention, the capture probes are commissioned to be synthesized by Ajitaikang Biotechnology (Beijing) Co., Ltd.
[0034] The invention provides a kit for detecting the full-length genome of rubella virus, comprising the capture probe, magnetic beads labeled with streptavidin and a library hybridization reaction reagent.
[0035] In the present invention, the streptavidin-labeled magnetic beads bind to the biotin on the capture probe through streptavidin, and then the capture probe and the target region DNA sequence targeted and bound to the capture probe are separated from the system by magnetic field force. The library hybridization reaction reagent preferably includes at least one of the following reagents: TargetSeq Hyb Bufferv2, Hyb Human Block, Blocking Oligo and RNase enzyme inhibitor. The library hybridization reaction reagent is used for the hybridization reaction of the capture probe, and is used for the capture probe to bind to a specific DNA sequence in the genomic library.
[0036] In the present invention, the kit preferably also includes RNA fragmentation reagents, reverse transcription reaction reagents, cDNA double-strand synthesis reaction reagents, linker connection reagents, purification reagents, PCR pre-reaction reagents and post-capture PCR amplification reaction reagents. The PCR pre-reaction reagents preferably include at least one of the following: PCR Master Mix containing UDG enzyme and UDI primers. The RNA fragmentation reagents, reverse transcription reaction reagents, cDNA double-strand synthesis reaction reagents, linker connection reagents, purification reagents, and PCR pre-reaction reagents are used to construct a Rubella virus genome library. The present invention has no special restrictions on the reagents for constructing the Rubella virus genome library, and reagents well known in the art can be used. The post-capture PCR amplification reaction reagents preferably include at least one of the following: PCR primers and post-capture PCR reaction premix. The post-capture PCR amplification reaction reagents are used to amplify the DNA sequence of the captured target area to obtain a large number of DNA sequences in the target area to meet the sequencing requirements.
[0037] The present invention provides the use of the capture probe or the kit in the detection of the full-length genome of rubella virus, the monitoring of rubella virus genome variation and / or the tracing analysis of the rubella virus genome.
[0038] In the present invention, in the application, the kit is used to obtain the full-length genome of the rubella virus, and the variation information of the rubella virus genome is obtained, and the variation information includes single base mutation and insertion and deletion mutation; by comparing and analyzing the variation information with the genome sequence in the database, the purpose of monitoring the variation of the rubella virus genome and / or tracing analysis is achieved;
[0039] In the present invention, the strain of Rubella virus preferably includes the 1E Rubella epidemic strain and / or the 2B Rubella epidemic strain.
[0040] In the present invention, the method for detecting the full-length genome of rubella virus is preferably to hybridize the rubella virus genome library and the capture probe, and separate the target region DNA sequence bound to the capture probe in the hybridization solution. Since the capture probe can cover the rubella virus genome 100%, a sequence covering the whole genome of rubella virus is obtained, and the whole genome of rubella virus is obtained by PCR amplification and second-generation sequencing. The method for tracing the source of the rubella virus genome is based on obtaining the full-length genome sequence information of rubella virus, and a large number of sample strains of the whole genome database can be established. Based on the database, the purpose of tracing the virus type in the rubella virus outbreak area can be achieved. The method for monitoring the variation of the rubella virus genome is preferably that the capture probe can effectively detect the mutation for the new mutation at any site on the rubella virus genome, and accurately monitor the variation of rubella virus.
[0041] The present invention provides a method for detecting the full-length genome of rubella virus based on the capture probe and second-generation sequencing, comprising the following steps:
[0042] Hybridizing the Rubella virus genome library of the sample to be tested with the capture probe to obtain a hybridization reaction solution;
[0043] separating the DNA fragment hybridized with the probe from the hybridization reaction solution;
[0044] The DNA fragment hybridized with the probe is used as a template for post-capture PCR amplification, the obtained PCR product is subjected to second-generation sequencing, and the sequencing result is subjected to data analysis to obtain the full-length genome of the rubella virus.
[0045] The present invention hybridizes the Rubella virus genome library of the sample to be tested with the capture probe to obtain a hybridization solution.
[0046] The present invention has no particular limitation on the method for constructing the Rubella virus genomic library of the sample to be tested, and a genomic library construction method well known in the art can be used, such as extraction and fragmentation of total RNA, reverse transcription and cDNA second-strand synthesis, addition of linkers and PCR pre-reaction, and fragment purification to obtain a genomic library.
[0047] In the present invention, the hybridization reaction system is preferably 30 μL, preferably including the following reagents: TargetSeq Hyb Buffer v213μL, Hyb Human Block 5μL, Blocking Oligo 2μL, RNaseBlock 5μL, Nuclease-Free Water 3μL and Target Probes 2 μL. The hybridization reaction procedure is preferably 80° C. for 5 min, and 50° C. for 12 to 18 h.
[0048] In the present invention, the method for separating the DNA fragments hybridized with the probe from the hybridization solution preferably comprises mixing the magnetic beads modified with streptavidin with the hybridization solution, combining the magnetic beads with the hybridization complex by utilizing the binding properties of streptavidin and biotin to form a ternary complex, and separating the ternary complex from the hybridization solution under the action of a magnetic field.
[0049] After obtaining the DNA fragment hybridized with the probe, the present invention uses the DNA fragment hybridized with the probe as a template for post-capture PCR amplification, performs second-generation sequencing on the obtained PCR product, performs data analysis on the sequencing results, and obtains the full-length genome of the rubella virus.
[0050] In the present invention, the reaction system of the post-capture PCR amplification is preferably 50 μL, preferably including the following reagents: 24 μL of DNA fragment suspension hybridized with the probe, 1 μL of Post PCR primers, and 25 μL of Post PCR Master Mix. The reaction procedure of the post-capture PCR amplification is preferably 95°C for 1 min;
[0051] 98℃20s, 60℃30s, 72℃30s, 7-12 cycles; 72℃5min.
[0052] In the present invention, the method for performing data analysis on sequencing results preferably includes preliminary filtering of raw sequencing data to obtain clean reads;
[0053] The host gene sequence is removed from the clean reads, and the obtained sequence is aligned to the viral genome to assemble a contig sequence;
[0054] The contig sequence is again depleted of the host gene sequence and then aligned to the viral genome sequence to obtain virus typing and sorting data;
[0055] The virus typing and sequencing data were aligned to the reference genome, and after correction of the variant sites, the full-length genome of the rubella virus was obtained.
[0056] In the present invention, since there are adapter information and low-quality sequence reads in the original sequence obtained by sequencing, in order to improve the quality of the sequencing data, the original sequence data is initially filtered. The method of the initial filtering is preferably to cut off the sequence with an average base quality value less than 20bp in an 8bp sliding window manner; remove the adapter sequence at the end of the sequence; if the first base or the last base of the sequence is less than 20bp, the base will be directly cut off; usually, if the remaining sequence length is less than 40 (double-end) after the removal is completed, the pair of sequences will be discarded.
[0057] In the present invention, the method for removing the host gene sequence is preferably to use Bowtie2 software to align the sequencing data to the reference genome of the host, and collect the sequences that cannot be aligned.
[0058] In the present invention, preferably, the collected unaligned sequences are aligned to the viral genome using bwa software. The viral genome refers to the rubella virus genome. The method for assembling contig sequences is preferably assembled using MEGAHIT software.
[0059] In the present invention, the contig sequence is again depleted of the host gene sequence and then aligned to the viral genome to obtain virus typing and sorting data. The viral genome refers to the Rubella virus genome.
[0060] In the present invention, clean reads are aligned to a reference genome, and the full-length genome of Rubella virus is obtained after correction of the variant sites. The reference genome is preferably a Rubella virus typing sequence ranked first in the virus typing ranking. The alignment is preferably performed using bwa software. The variant site correction is preferably performed using samtools software for mutation analysis, and after obtaining the mutation site, iVar software is used to perform variant site correction.
[0061] In the present invention, the above detection method is adopted to combine probe hybridization capture and second-generation sequencing technology, so that the whole genome sequence of rubella virus can be obtained quickly and at low cost.
[0062] The following is a detailed description of a capture probe for full-length genome detection of Rubella virus provided by the present invention, a kit thereof, and applications thereof in conjunction with the embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0063] Example 1
[0064] Design of a capture probe for full-length genome detection of rubella virus
[0065] Probes were designed based on the complete genome sequence of rubella virus downloaded from the NCBI Virus database (TaxonomyID: 11041) (GenBank numbers are KT962863.1, KT962864.1, KT962865.1, KT962866.1, KT962867.1, KT962868.1, KT962869.1KT962870.1, KT962871.1, and the GenBank numbers of 1E-L2 and 2B-L2c gene subtypes have not been published yet). All variant sequences were used to design oligonucleotide probes that were complementary to the sequences in the database using the principle of complementary base pairing.
[0066] Due to the complex structure of the genome sequence, there are irregular regions, such as high GC, high AT regions, Alu sequences, etc. At the same time, due to the limitation of the second-generation sequencing read length and the need to obtain the full-length sequence, probe design becomes particularly critical, and it is necessary to comprehensively weigh the coverage, uniformity, capture efficiency and other factors of the probe. The following are the principles of probe design in liquid phase capture technology:
[0067] 1. Probe length: The probe is designed to be 100 nt long.
[0068] 2. Number of probe layers: that is, the average number of probes covering the target area. The shingled probe sequence design method is used to cover the target area with multiple layers of probes. At the same time, during the probe sequence design process, the thermodynamic stability is evaluated and probe compensation is performed on areas with low thermodynamic stability.
[0069] 3. Specificity: that is, the uniqueness of the probe in the genome. The higher the specificity, the higher the capture efficiency of the probe. Probes should be designed to avoid low-complexity regions; but in special cases, for example, some hot spots happen to be located in low-complexity regions, then it is necessary to comprehensively evaluate the sequence of the region and adjacent regions and place the probes with caution.
[0070] 4. Binding ability: The probe capture ability is strongest in the area with a GC content of about 50%. The probe binding ability is strong in the high GC area, but the DNA fragments themselves have stronger binding ability (longer length), and the probe competition resistance is greater; the DNA fragments in the high AT area have weak binding ability, but the probe's ability to bind to them is also weak. Therefore, in the high GC and high AT areas, the number of probes needs to be appropriately increased to compensate for the disadvantages in competition resistance and binding ability.
[0071] 5. Probe preparation: The probe template is synthesized by high-throughput electrochemical synthesis. The synthesized oligo passes through pool mixing and quality inspection. The qualified oligopool products will be used to synthesize RNA probes. The probe uses biotin-labeled NTP and nucleic acid analogs as synthetic raw materials and is prepared by in vitro transcription.
[0072] 6. Secondary structure: The probe itself should be prevented from forming a hairpin structure and the probes should be prevented from forming dimers, otherwise it will affect the binding of the probe to the target DNA.
[0073] 7. For pathogenic microorganisms with multiple highly variable sequences, please note:
[0074] (a) Design probes for all variants to avoid omissions;
[0075] (b) All variant probes are merged to remove redundancy and prevent the depth from being too high in highly conserved regions.
[0076] After comprehensive evaluation, a total of 796 probes were designed and synthesized, with coverage of up to 100% for all sequences in the database, and ensuring uniform and effective capture depth in each region of the genome.
[0077] The sequences of the designed capture probes are shown in Table 1.
[0078] Table 1 Rubella virus genome capture probe
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101]
[0102]
[0103]
[0104]
[0105]
[0106]
[0107]
[0108]
[0109] Example 2
[0110] A method for detecting the full-length genome of rubella virus based on capture probes and second-generation sequencing, comprising the following steps:
[0111] (I) Extraction of genomic RNA from the sample to be tested
[0112] The samples to be tested were clinical samples and virus isolates of rubella virus collected by the National Laboratory from 2001 to 2022. RNA was extracted from the samples using QIAamp Viral RNA Minikit (Cat. No. 52906, Qiagen, Germany). RNA concentration was quantified using Qubit RNA HS assay kit and Qubit Fluorometer (Life Technologies, USA).
[0113] (II) Library preparation
[0114] 1. RNA fragmentation
[0115] 1.1 Take out the RNA sample from the -80℃ refrigerator in advance, and take out the Fast Frag Buffer from the -20℃ refrigerator in advance, place it on an ice box to melt, vortex briefly to mix and centrifuge it instantaneously, and place it on an ice box for later use.
[0116] 1.2 Prepare the reaction system on an ice box according to Table 2:
[0117] Table 2 Fragmentation reaction system
[0118] Reagents volume RNA samples 13μL (total volume 10ng~1μg) Fast Frag Buffer 4μL Total volume 17μL
[0119] 1.3 Use a pipette to mix or vortex to mix, and centrifuge briefly.
[0120] 1.4 Set the PCR instrument parameters as follows, place the reaction solution on the PCR instrument, and run the program according to Table 3:
[0121] Table 3 Reaction procedure
[0122]
[0123] 1.5 When the temperature of the PCR instrument drops to 4°C, take out the PCR tube, centrifuge it momentarily, and proceed to STEP 2 immediately.
[0124] 2. Reverse Transcription
[0125] 2.1 Take out the Fast First Strand Buffer in the kit from the -20℃ refrigerator in advance, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantly, and place it on an ice box for later use.
[0126] 2.2 Take out the Fast First Strand Enzyme in the kit from the -20℃ refrigerator, invert and centrifuge briefly, and place on an ice box for later use.
[0127] 2.3 Prepare the reaction system on an ice box according to Table 4:
[0128] Table 4 Reverse transcription reaction system
[0129] Reagents volume Sample from the end of STEP1 reaction 17μL Fast First Strand Buffer 6μL Fast First Strand Enzyme 2μL Total volume 25μL
[0130] 2.4 Use a pipette to mix (avoid vigorous shaking) and centrifuge briefly.
[0131] 2.5 Set the PCR instrument parameters as follows, place the reaction solution on the PCR instrument, and run the program according to Table 5:
[0132] Table 5 Reverse transcription reaction system
[0133]
[0134] 2.6 When the temperature of the PCR instrument drops to 4°C, take out the PCR tube, centrifuge it momentarily, and proceed to STEP 3 immediately.
[0135] 3. Synthesis of cDNA second strand and addition of "A" at the 3' end
[0136] 3.1 Take out the Fast Second Strand Buffer with dUTP in the kit from the -20℃ refrigerator in advance, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantaneously, and place it on an ice box for later use.
[0137] 3.2 Take out the Fast Second Strand Enzyme in the kit from the -20℃ refrigerator, invert to mix and centrifuge briefly, and place on an ice box for later use.
[0138] 3.3 Prepare the reaction system on an ice box according to Table 6:
[0139] Table 6 cDNA second-strand synthesis system
[0140] Reagents volume Sample from the end of step 2 reaction 25μL Fast Second Strand Buffer with dUTP 30μL Fast Second Strand Enzyme 5μL Total volume 60μL
[0141] 3.4 Use a pipette to mix (avoid vigorous shaking) and centrifuge briefly.
[0142] 3.5 Set the PCR instrument parameters as follows, place the reaction solution on the PCR instrument, and run the program according to Table 7:
[0143] Table 7 cDNA second-strand synthesis reaction program
[0144]
[0145]
[0146] 3.6 When the temperature of the PCR instrument drops to 4°C, take out the PCR tube, centrifuge it momentarily, and proceed to STEP 4 immediately.
[0147] 4. Connector connection
[0148] 4.1 Take the Adapter out of the -20℃ refrigerator in advance and place it on an ice box to thaw. After thawing, vortex briefly to mix and centrifuge it instantly. Place it on an ice box for later use.
[0149] 4.2 Dilute the Adapter (15 μM) to an appropriate concentration in advance according to the amount of RNA used for library construction:
[0150] Table 8 Input RNA amount and adapter ratio
[0151] RNA input amount Connector concentration Dilution multiple 100ng~500ng 7.5μM 2 times 50ng 3.75μM 4 times 25ng 1.5μM 10 times 10ng 0.75μM 20 times
[0152] 4.3 Take out the Fast Ligation Buffer in the kit from the -20℃ refrigerator in advance, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantaneously, and place it on an ice box for later use.
[0153] 4.4 Take out the Fast Ligase Mix from the -20℃ refrigerator, invert to mix, centrifuge briefly, and place on an ice box for later use.
[0154] 4.5 Prepare the reaction system on an ice box according to Table 9:
[0155] Table 9 Linker Addition Reaction System
[0156] Reagents volume Sample from the end of STEP3 reaction 60μL Fast Ligation Buffer 30μL Fast Ligase Mix 5μL Adapter (after dilution) 5μL Total volume 100μL
[0157] If a single experiment processes a large number of samples and the reaction solution needs to be pre-mixed, please do not pre-mix the Adapter. The best operation method is to first mix the Adapter (after dilution) with the sample after the Step 3 reaction, and then add the pre-mixed reaction solution, which can effectively reduce the self-ligation of the adapter.
[0158] 4.6 Use a pipette to mix (avoid violent shaking), and centrifuge momentarily.
[0159] 4.7 Set the parameters of the PCR instrument (close the hot cover or do not cover the hot cover), place the PCR tube on the PCR instrument, and run the program according to Table 10:
[0160] Table 10 Linker addition reaction procedure
[0161]
[0162] 4.8 When the temperature of the PCR instrument drops to 4°C, take out the PCR tube, centrifuge it momentarily, and proceed to STEP 5 immediately.
[0163] 5. Post-ligation purification
[0164] 5.1 Prepare 80% ethanol with anhydrous ethanol and Nuclease-Free Water in advance and keep it at room temperature for later use. Please try to use freshly prepared 80% ethanol for magnetic bead purification. (The magnetic beads used for purification are IGT TM Pure Beads or Agencourt AMPure XP)
[0165] 5.2 Take out the purified magnetic beads from the 4℃ refrigerator in advance, mix them and place them at room temperature for 30 minutes. Vortex the purified magnetic beads that have been equilibrated to room temperature and set aside.
[0166] 5.3 Add 0.45 times volume (45 μL) of purified magnetic beads to 100 μL of reaction solution after STEP 4, mix by pipetting or vortexing, and let stand at room temperature for 5 minutes.
[0167] 5.4 Centrifuge briefly and place the PCR tube on a magnetic rack for 3 minutes to wait for the solution to clarify.
[0168] 5.5 Keep the PCR tube on the magnetic rack, carefully remove the supernatant, add 200 μL 80% ethanol solution into the PCR tube, and let it stand for 30 seconds.
[0169] 5.6 Keep the PCR tube on the magnetic rack, discard the supernatant, add 200 μL 80% ethanol solution to the PCR tube again, let it stand for 30 seconds, and discard the supernatant.
[0170] 5.7 Cover the tube cap and centrifuge briefly to remove the residual ethanol to the bottom of the tube. Place it on the magnetic rack and carefully use a 10μL pipette to remove the residual ethanol at the bottom, being careful not to absorb the magnetic beads.
[0171] 5.8 Keep the PCR tube on the magnetic rack and let it stand at room temperature for 3 to 5 minutes to dry the magnetic beads and allow the residual ethanol to evaporate completely.
[0172] 5.9 Add 22 μL of Nuclease-Free Water, remove the PCR tube from the magnetic stand, mix by pipetting or vortexing, and let stand at room temperature for 2 minutes.
[0173] 5.10 Centrifuge briefly and place the PCR tube on a magnetic rack for 2 minutes to wait for the solution to clarify.
[0174] 5.11 Use a pipette to aspirate 20 μL of supernatant, transfer it to a new PCR tube, mark it, and prepare for STEP 6.
[0175] 6. Pre-PCR reaction
[0176] 6.1 Take out the PCR Master Mix with UDG in the kit from the -20℃ refrigerator in advance, place it on an ice box to melt, invert and mix after melting, centrifuge it instantly, and place it on an ice box for later use.
[0177] 6.2 Take out the UDI Primer in the kit from the -20℃ refrigerator in advance, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantaneously, and place it on an ice box for later use.
[0178] 6.3 Prepare the PCR reaction solution on an ice box according to Table 11 below. Please record the Index number used:
[0179] Table 11 Pre-PCR reaction system
[0180] Reagents volume Sample from the end of STEP5 reaction 20μL PCR Master Mix with UDG 25μL UDI Primer 5μL Total volume 50μL
[0181] The UDI Primer sequence is as follows:
[0182] 5'-AATGATACGGCGACCACCGAGATCTACAC-i5Index-ACACTCTTTCCCTACACGACGCCTTCCGATCT (SEQ ID NO: 797);
[0183] 5'-CAAGCAGAAGACGGCATACGAGAT-i7Index-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT (SEQ ID NO: 798).
[0184] 6.4 Use a pipette to mix (avoid violent shaking), and centrifuge momentarily.
[0185] 6.5 Set the PCR program as follows, place the PCR tube on the PCR instrument, and run the program according to the records in Table 12 and Table 13:
[0186] Table 12 Pre-PCR reaction program
[0187]
[0188] Table 13 Relationship between sample volume and PCR cycle number
[0189] Input sample size PCR cycle number (library output 1 μg) 500ng 7 250ng 7 100ng 9 50ng 10 25ng 11 10ng 12
[0190] 6.6 When the temperature of the PCR instrument drops to 4°C, take out the PCR tube, centrifuge briefly, and proceed to STEP 7 immediately.
[0191] 7. Purification after PCR amplification
[0192] 7.1 Prepare 80% ethanol with anhydrous ethanol and Nuclease Free Water in advance and keep it at room temperature for later use. Please try to use freshly prepared 80% ethanol for magnetic bead purification. (The magnetic beads used for purification are IGT TM Pure Beads or Agencourt AMPure XP)
[0193] 7.2 Take out the purified magnetic beads from the 4℃ refrigerator in advance, mix them and place them at room temperature for equilibration for 30 minutes. Vortex the purified magnetic beads that have been equilibrated to room temperature and set aside.
[0194] 7.3 Add 0.9 times the volume of purified magnetic beads (45 μL) to the 50 μL reaction solution after Step 6, mix by pipetting or vortexing, and let stand at room temperature for 5 minutes.
[0195] 7.4 Centrifuge briefly and place the PCR tube on a magnetic rack for 3 minutes to wait for the solution to clarify.
[0196] 7.5 Keep the PCR tube on the magnetic rack, carefully remove the supernatant, add 200 μL 80% ethanol solution into the PCR tube, and let it stand for 30 seconds.
[0197] 7.6 Keep the PCR tube on the magnetic rack, discard the supernatant, add 200 μL 80% ethanol solution to the PCR tube again, let it stand for 30 seconds, and discard the supernatant.
[0198] 7.7 Cover the tube cap and centrifuge briefly to remove the remaining ethanol to the bottom of the tube. Place the PCR tube on the magnetic rack and carefully use a 10μL pipette to remove the remaining ethanol at the bottom, being careful not to absorb the magnetic beads.
[0199] 7.8 Keep the PCR tube on the magnetic rack and let it stand at room temperature for 3 to 5 minutes to dry the magnetic beads and allow the residual ethanol to evaporate completely.
[0200] 7.9 Add 30 μL of Nuclease-Free Water, remove the PCR tube from the magnetic stand, mix by pipetting or vortexing, and let stand at room temperature for 2 minutes.
[0201] 7.10 Centrifuge briefly and place the PCR tube on a magnetic rack for 2 minutes to wait for the solution to clarify.
[0202] 7.11 Use a pipette to aspirate 28 μL of supernatant, transfer it to a new PCR tube and mark it.
[0203] 7.12 Take 1 μL of library and use Qubit ds DNA HS Assay Kit reagent to measure the library concentration on Qubit 4.0 Fluorometer and record the library concentration.
[0204] 7.13 Take 1 μL of sample and use the fragment analyzer to measure the fragment length. After the experiment is completed, you can arrange for sequencing.
[0205] (III) Targeted capture
[0206] 1. Preliminary preparation for hybrid capture experiment
[0207] This experiment requires about two rounds of liquid phase probe hybridization capture experiments.
[0208] 1.1 Take out Hyb Human Block and RNase Block from the -20℃ refrigerator, place them on an ice box to melt, vortex briefly to mix, centrifuge them instantaneously, and place them on an ice box for temporary storage;
[0209] 1.2 Will be equipped with Take the Blocking Oligo out of the -20℃ freezer, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantaneously, and place it on an ice box for temporary storage;
[0210] 1.3 Take out the probe to be used from the -80℃ refrigerator, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantaneously, and place it on an ice box for temporary storage;
[0211] 1.4 Take out the library to be hybridized and captured from the -20℃ refrigerator, place it on an ice box to melt, vortex briefly to mix, centrifuge it instantaneously, and place it on an ice box for temporary storage;
[0212] 1.5 TargetSeq Take out Hyb Buffer v2, melt at room temperature, vortex briefly to mix, and centrifuge briefly. If there is precipitation, transfer TargetSeq Heat Hyb Buffer v2 in a 37°C water bath and use it after the reagent is completely dissolved.
[0213] 2. Library and probe hybridization
[0214] 2.1 When hybridizing a single library, add 750 ng of the library to a PCR tube and mark it; when hybridizing multiple libraries, add 500 ng of each library.
[0215] 2.2 Place the PCR tube into a vacuum concentrator centrifuge, open the PCR tube cover, and concentrate to dryness.
[0216] 2.3 After the library is concentrated, prepare the hybridization reaction solution as shown in Table 14:
[0217] Table 14 Hybridization reaction system
[0218]
[0219] 2.4 Add the hybridization reaction solution to the dried library, vortex for 30 seconds to ensure that the DNA dried at the bottom of the tube is dissolved, and centrifuge briefly.
[0220] 2.5 Set the PCR instrument parameters as follows, place the hybridization reaction solution on the PCR instrument, and run the program according to Table 15:
[0221] Table 15 Hybridization reaction program
[0222]
[0223] 2.6 The recommended hybridization time is 12 to 18 hours. Perform STEP 3 30 minutes before the end of the program.
[0224] 3. Preparation before capture experiment
[0225] 3.1 In advance Cap Beads were taken out of the 4°C refrigerator, mixed thoroughly and equilibrated at room temperature for 30 min.
[0226] 3.2 Take out Wash Buffer 1. If there is precipitation, please heat Wash Buffer 1 in a 37℃ water bath and use it after the precipitation is completely dissolved.
[0227] 3.3 TargetSeq Take out Wash Buffer2v2 and preheat it in a 50℃ water bath.
[0228] 3.4 Take 50 μL Add Cap Beads to a new PCR tube and place it on a magnetic rack for 1 min. Wait for the solution to become clear and discard the supernatant.
[0229] 3.5 Remove the PCR tube from the magnetic stand, add 180 μL of Binding Buffer and mix by pipetting or vortexing to resuspend the magnetic beads.
[0230] 3.6 After instant centrifugation, place the PCR tube on a magnetic rack for 1 minute, wait for the solution to become clear, and discard the supernatant;
[0231] 3.7 Repeat steps 3.5 to 3.6 twice, washing the magnetic beads three times with Binding Buffer;
[0232] 3.8 Remove the PCR tube from the magnetic stand, add 180 μL Binding Buffer, pipette or vortex to mix, and proceed to STEP 4 immediately.
[0233] 4. Target region DNA capture
[0234] 4.1 Keep the hybridization product of STEP 2 on the PCR instrument and add 180 μL of the prepared product of STEP 3 Add CapBeads to the hybridization product and mix by pipetting.
[0235] 4.2 Cover the tube cap, remove the PCR tube from the PCR instrument, place it on a vertical rotating mixer, rotate at no more than 10 rpm, and combine at room temperature for 30 minutes (if the laboratory does not have a vertical rotating mixer, you can combine at room temperature for 30 minutes, during which time you can mix by turning it upside down several times every 5 minutes).
[0236] 4.3 Remove the PCR tube, centrifuge it instantly, place it on a magnetic rack for 2 minutes, and discard the supernatant after the solution becomes clear.
[0237] 4.4 Remove the PCR tube from the magnetic rack, add 150 μL of Wash Buffer 1 to the PCR tube and gently pipette to mix to resuspend the magnetic beads, replace the tube cap with a new one, and then place it on a vertical rotating mixer to wash at room temperature for 15 minutes, with a speed not exceeding 10 rpm.
[0238] 4.5 Remove the PCR tube, centrifuge it instantly, place it on a magnetic rack for 2 minutes, and discard the supernatant after the solution becomes clear.
[0239] 4.6 Remove the PCR tube from the magnetic stand and add 150 μL of 50°C preheated TargetSeq Wash Buffer 2v2, gently pipette to mix, centrifuge briefly, place on a metal bath, and incubate at 50°C for 10 min.
[0240] 4.7 Remove the PCR tube, centrifuge it instantly, place it on a magnetic rack for 2 minutes, and discard the supernatant after the solution becomes clear.
[0241] 4.8 Repeat steps 4.6 to 4.7 twice, using TargetSeq Wash the beads three times with Wash Buffer 2v250℃.
[0242] 4.9 Keep the PCR tube on the magnetic rack, add 200 μL 80% ethanol into the PCR tube, let it stand for 30 seconds and then completely discard the ethanol solution (a 10 μL pipette can be used to discard the residual ethanol), and dry the magnetic beads at room temperature to allow the residual ethanol to evaporate completely.
[0243] 4.10 Add 24 μL Nuclease-Free Water to the PCR tube, remove the PCR tube from the magnetic stand, vortex briefly to mix and resuspend the magnetic beads, and perform the amplification reaction of STEP 5.
[0244] 4.11 Keep the PCR tube on the magnetic rack, add 200 μL 80% ethanol into the PCR tube, let it stand for 30 seconds and then completely discard the ethanol solution (you can use a 10 μL pipette to discard the residual ethanol), and dry the magnetic beads at room temperature to allow the residual ethanol to completely evaporate (during the drying process, pay attention to the surface of the magnetic beads to avoid over-drying of the magnetic beads).
[0245] 4.12 Add 24 μL Nuclease-Free Water to the PCR tube, remove the PCR tube from the magnetic stand, vortex briefly to resuspend the magnetic beads, and perform the amplification reaction of STEP 5.
[0246] 5. Post-capture PCR Amplification
[0247] 5.1 Take out Post PCR Master Mix and Post PCR Primer from the -20℃ refrigerator in advance, place them on an ice box to melt, and store them on an ice box temporarily after melting.
[0248] 5.2 Before the experiment, please check again whether the Post PCR Primer is used correctly, briefly vortex Post PCR Master Mix and Post PCR Primer, and centrifuge them instantly.
[0249] 5.3 Prepare the PCR reaction solution according to Table 16. Note that this step is a PCR reaction with magnetic beads:
[0250] Table 16 Post-capture PCR reaction system
[0251] Reagents volume STEP4 Magnetic bead suspension obtained 24μL Post PCR Primer 1μL Post PCR Master Mix 25μL Total volume 50μL
[0252] Among them, the specific sequence of Post PCR Primer is as follows:
[0253] 5'-AATGATACGGCGACCACCGA (SEQ ID NO: 799);
[0254] 5'-CAAGCAGAAGACGGCATACGA (SEQ ID NO: 800).
[0255] 5.4 After preparation, use a pipette to mix, and quickly transfer to the PCR instrument. Do not use the vortex followed by centrifugation method to mix.
[0256] 5.5 Set the PCR instrument program as follows, place the PCR reaction solution on the PCR instrument, and run the program according to Table 17:
[0257] Table 17 PCR reaction program
[0258]
[0259] After the 5.6 procedure is completed, proceed to the magnetic bead purification in STEP 6.
[0260] The number of PCR cycles can refer to the probe Target Prober tube wall label parameters or probe description files. The number of Post-PCR cycles is related to the total amount of library input during hybridization. When the amount of library input during hybridization is large, the number of Post-PCR cycles can be appropriately reduced. Because the amount of library required for sequencing on the MGI platform is large, it is recommended to add two more cycles.
[0261] 6. Post-amplification purification
[0262] 6.1 Take out the purified magnetic beads, mix well and equilibrate at room temperature for 30 minutes.
[0263] 6.2 Add 1.1 times the volume of magnetic beads (55 μL) to the PCR product of STEP 5, pipette or vortex to mix, and let stand at room temperature for 5 minutes.
[0264] 6.3 Centrifuge briefly and place the PCR tube on a magnetic rack for 3 minutes to wait for the solution to become clear.
[0265] 6.4 Keep the PCR tube on the magnetic rack, discard the supernatant, add 200 μL 80% ethanol solution into the PCR tube, and let it stand for 30 seconds.
[0266] 6.5 Keep the PCR tube on the magnetic rack, discard the supernatant, add 200μL 80% ethanol solution to the PCR tube again, let it stand for 30s and then completely discard the supernatant (centrifuge the hanging liquid to the bottom of the tube, and then use a 10μL pipette to discard the ethanol solution remaining at the bottom).
[0267] 6.6 Keep the PCR tube on the magnetic rack and let it stand at room temperature for 3 to 5 minutes to dry the magnetic beads and allow the residual ethanol to evaporate completely (during the drying process, pay attention to the surface of the magnetic beads to avoid over-drying of the magnetic beads).
[0268] 6.7 Add 25 μL of Nuclease-Free water, remove the PCR tube from the magnetic stand, mix by pipetting or vortexing, and let stand at room temperature for 2 minutes.
[0269] 6.8 Centrifuge briefly and place the PCR tube on a magnetic rack for 2 minutes to wait for the solution to clarify.
[0270] 6.9 Use a pipette to aspirate 23 μL of supernatant and transfer it to a new PCR tube; store the captured library in a -20°C refrigerator. The captured library can be stored in a -20°C refrigerator for one month.
[0271] 6.10 Take 1 μL of library and use Qubit dsDNA HS Assay Kit reagent to measure the library concentration on Qubit 4.0 Fluorometer and record the library concentration.
[0272] 6.11 Take 1 μL of library and use fragment analyzer to check the fragment quality. The fragment size should be basically consistent with the pre-library size.
[0273] On-line sequencing.
[0274] 1 μL was taken from the probe hybridization capture library and quantified using the Qubit ds DNA HS Assay Kit, and the library concentration was recorded; 1 μL of the sample was taken and the fragment length was measured using the Agilent 2100 Bioanalyzer system (Agilent DNA 1000 Kit), and the library length was between 250 bp and 400 bp. The probe hybridization capture library was sequenced using the NovaSeq 6000 (Illumina) sequencing platform to obtain the raw sequencing data.
[0275] (IV) Data Analysis
[0276] In the raw data obtained by sequencing, there will be a small number of reads containing adapter information, low-quality bases, etc. In order to ensure the quality of information analysis, it is necessary to perform preliminary filtering on the Raw reads to obtain Clean reads, and subsequent analysis is based on Clean reads. The content of data filtering is mainly as follows: using an 8bp sliding window, cut off the sequences with an average base quality value less than 20; remove the adapter sequence at the end of the sequence; if the first base or the last base of the sequence is less than 20, the base will be directly cut off; usually, if the remaining sequence length is less than 40 (double-end) after the removal is completed, the pair of sequences will be discarded.
[0277] Removing host sequences: Since the host genome sequences will still remain in the sequencing data, Bowtie2 sequencing data is first used to align to the host reference genome to obtain the unaligned sequences (unmapR1 & unmapR2). This part of the unmap sequence is the viral sequence information that we may actually need.
[0278] Virus genome alignment: Use bwa software to align the unmapped sequence to the viral genome (the reference species sequence information is designed as the alignment template), and MEGAHIT software to assemble the reads aligned to the genome into contig sequences. Then use blastn to align the contig sequences with the host genome, remove the host sequences again, and obtain the non-human contig file. Then align the non-human contig sequence to the viral genome sequence to obtain the possible virus typing and sorting results-virus.txt.
[0279] Obtain the full-length genome sequence of rubella virus: use the results-virus-top1 typing sequence ranked first in the possible virus typing ranking as the reference genome, use bwa software to align clean reads to the reference genome, obtain the aligned bam file, use samtools software to perform mutation analysis, obtain the variant sites, use iVar software to correct the variant sites of the genome, and obtain the final full-length genome sequence of rubella virus.
[0280] The results are shown in Table 18.
[0281] Table 18 Full-length genome sequencing results of Rubella virus in the tested samples
[0282] Reference genome KT962863.1 KT962870.1 KT962867.1 KT962866.1 KT962864.1 Genome starting coordinates 0 0 0 0 0 Genome terminal coordinates 9762 9762 9762 9762 9762 Reference genome length (bp) 9762 9762 9762 9762 9762 Sequencing data coverage length 9762 9762 9762 9762 9762 Coverage (%) 100 100 100 100 100 Sequencing base number (bp) 191867780 224783002 316048547 151178408 169171204 Average sequencing depth 19654.56 23026.33 32375.39 15486.42 17329.56 4× Coverage (%) 100 100 100 99.99 100 10× Coverage (%) 99.99 99.94 99.98 99.87 99.99 20×Coverage(%) 99.93 99.68 99.96 99.68 99.97 10%×Coverage(%) 94.31 97.43 99.89 93.71 97.56 20%×Coverage(%) 92.45 94.56 99.88 91.56 96.27 50%×Coverage(%) 85.96 88.29 99.86 84.76 91.44
[0283] Comparative Example 1
[0284] A method for detecting rubella virus genome based on first-generation sequencing
[0285] The RT-PCR method was used to amplify the target nucleotide sequence of the rubella virus for genotyping, and the amplified product was sequenced using the first-generation sequencing technology. The sequencing results were spliced in multiple steps to obtain the genome of the sample.
[0286] 1. Sample description: Sample 1 is 1E genotype Rubella virus, and sample 2 is 2B genotype Rubella virus.
[0287] 2. Kit: Qiagen One-step RT-PCR kit (Qiagen CAT#210210 or 210212)
[0288] The specific sequences of the PCR amplification primers are shown in Table 19.
[0289] Table 19 Primer sequences
[0290]
[0291]
[0292] Note: Primers 1 to 14 are primers for amplification of 1E genotype Rubella virus; Primers 15 to 28 are primers for amplification of 2B genotype Rubella virus.
[0293] 3. Prepare the PCR amplification reaction system according to Table 20, and perform PCR amplification according to the reaction procedure in Table 21.
[0294] Table 20 PCR amplification reaction system
[0295] Reagents volume 5×Qiagen One-Step RT-PCR Buffer 5μL Q-solution 5μL dNTP mix 1μL Forward primer (20 μM) 1μL Reverse primer (20 μM) 1μL Qiagen One-Step Enzyme Mix 1μL <![CDATA[ddH2O]]> 7μL RNA 4μL Total volume 25μL
[0296] Table 21 PCR amplification reaction program
[0297]
[0298] 4. Sequence determination: The obtained PCR product was sent to Biotechnology Co., Ltd. for sequence determination.
[0299] 5. Sequence splicing and organization: Sequencher5.0 software was used to organize and splice the sequences. To ensure accuracy, each fragment was tested in both forward and reverse directions.
[0300] 6. Sequence the obtained sample fragments and splice them to obtain the first-generation whole genome sequence, which is compared with the whole genome sequence obtained based on probe hybridization capture and second-generation sequencing technology to verify the sequence consistency.
[0301] The first generation sequencing results and the second generation sequencing results are shown in Table 22. The full length of the genome of sample 1 is 9762 bp, and there are only 3 different sites in the genome sequences obtained by the two sequencing methods (see Figure 1 to Figure 3 ), with an accuracy of 99.97%. The genome of sample 2 is 9761 bp in length, and there are only two different sites in the whole genome sequence obtained by the two sequencing methods (see Figure 4-5 ), with an accuracy rate of 99.98%. This shows that the present invention can achieve the purpose of accurately and efficiently detecting the genome of rubella virus based on probe hybridization capture and second-generation sequencing technology.
[0302] Table 22 Comparison of first generation sequencing and second generation sequencing results of the same sample
[0303]
[0304] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A capture probe for full-length genome detection of rubella virus, It is characterized in that The nucleotide sequences of the capture probes are shown in SEQ ID NO: 1 to SEQ ID NO:
796.
2. The capture probe according to claim 1, It is characterized in that The capture probe is labeled with biotin.
3. A kit for detecting the full-length genome of rubella virus, It is characterized in that The method comprises the capture probe according to claim 1 or 2, magnetic beads labeled with streptavidin and a library hybridization reaction reagent.
4. The kit for detecting the full-length genome of rubella virus according to claim 3, It is characterized in that The library hybridization reaction reagents include at least one of the following reagents: TargetSeq Hyb Buffer v2, Hyb Human Block, Blocking Oligo and RNase Inhibitors.
5. A kit for detecting the full-length genome of rubella virus according to claim 3 or 4, It is characterized in that The kit also includes RNA fragmentation reagents, reverse transcription reaction reagents, cDNA double-strand synthesis reaction reagents, adapter connection reagents, purification reagents, PCR pre-reaction reagents and post-capture PCR amplification reaction reagents.
6. The kit for detecting the full-length genome of Rubella virus according to claim 5, It is characterized in that The PCR pre-reaction reagents include PCR MasterMix containing UDG enzyme and / or UDI primers; The post-capture PCR amplification reaction reagents include PCR primers and / or post-capture PCR reaction premix.
7. Use of the capture probe according to claim 1 or 2 or the kit according to any one of claims 3 to 6 in the detection of the full-length genome of rubella virus, the monitoring of rubella virus genome variation and / or the tracing analysis of the rubella virus genome.
8. The use according to claim 7, It is characterized in that In the application, the kit is used to obtain the full-length genome of the rubella virus, and obtain the variation information of the rubella virus genome, wherein the variation information includes single-base mutations and insertion-deletion mutations; and the purpose of monitoring the variation of the rubella virus genome and / or tracing analysis is achieved by comparing and analyzing the variation information with the genome sequence in the database; Preferably, the strain of Rubella virus includes the 1E rubella epidemic strain and / or the 2B rubella epidemic strain.
9. A method for detecting the full-length genome of Rubella virus based on the capture probe according to claim 1 or 2 and the second generation sequencing, It is characterized in that The following steps are involved: Hybridizing the Rubella virus genome library of the sample to be tested with the capture probe to obtain a hybridization reaction solution; separating the DNA fragment hybridized with the probe from the hybridization reaction solution; The DNA fragment hybridized with the probe is used as a template for post-capture PCR amplification, the obtained PCR product is subjected to second-generation sequencing, and the sequencing result is subjected to data analysis to obtain the full-length genome of the rubella virus.
10. The method according to claim 9, It is characterized in that The method for analyzing the sequencing results includes preliminary filtering the original sequencing data to obtain clean reads; The host gene sequence is removed from the clean reads, and the obtained sequence is aligned to the viral genome to assemble a contig sequence; The contig sequence is again depleted of the host gene sequence and then aligned to the viral genome sequence to obtain virus typing and sorting data; The virus typing and sequencing data were aligned to the reference genome, and after correction of the variant sites, the full-length genome of the rubella virus was obtained.
Citation Information
Patent Citations
Parallel-connection probes, gene chip, kit and method for rubella virus detection
CN106048086A
Capture probe set for hepatitis B virus gene detection
CN112322783A
Capture probe set, method and kit for detecting pathogenic microorganisms and application
CN112813196A
Efficient Deep Sequencing and Rapid Genomic Speciation of RNA Viruses (vRNAseq)
US20160076094A1
Cited By
Capture probe for detecting whole genome of human parainfluenza virus as well as kit and application thereof
CN119351631A
Probe group and kit for capturing full-length genome of respiratory syncytial virus
CN120230885A
Capture probe group and kit for measles virus full-length genome and sequencing method of measles virus full-length genome
CN120249560A
Probe set for specifically enriching RSV whole genome in respiratory tract sample, kit and application
CN121344267A
